Randall Jess T, Aldoss Osamah, Khan Asra, Challman Melissa, Hiremath Gurumurthy, Qureshi Athar M, Bansal Manish
Texas Children's Hospital, 6651 Main Street, E1920, Houston, TX 77030 USA.
J Invasive Cardiol. 2019 May;31(5):141-145. doi: 10.25270/jic/18.00292. Epub 2019 Feb 15.
Traditional approaches to pediatric cardiac catheterization have relied on femoral venous access. Upper- extremity venous access may enable cardiac catheterization procedures to be performed safely for diagnostic and interventional catheterizations. The objective of this multicenter study was to demonstrate the feasibility and safety of upper-extremity venous access in a pediatric cardiac catheterization laboratory.
A retrospective chart review of all patients who underwent cardiac catheterization via upper-extremity vascular access was performed.
Eighty-two cardiac catheterizations were attempted via upper-extremity vein on 72 patients. Successful access was obtained in 75 catheterizations (91%) in 67 patients. Median age at catheterization was 18.79 years (interquartile range [IQR], 13.02-32.75 years; n = 75) with a median weight of 59.4 kg (IQR, 43.3-76.5 kg; n = 75). The youngest patient was 4.1 months old, weighing 4.3 kg. Local anesthesia or light sedation was utilized in 46 procedures (61%). Diagnostic right heart catheterization was the most common procedure (n = 65; 87%), with intervention performed via the upper extremity in 8 cases (11%). Median fluoroscopy time was 10.02 min (IQR, 2.87-36.26 min; n = 75), with dose area product/kg of 3.765 μGy•m²/kg (IQR, 0.74-34.12 μGy•m²/kg; n = 64). Median sheath duration time was 48 min (IQR, 19.5-147 min; n = 57) and median total procedure time was 116 min (IQR, 80.5-299 min; n = 65). Median length of stay for outpatient procedures was 5.37 hr (IQR, 4.25-6.92 hr; n = 27). There were no procedural complications.
Upper-extremity venous access is a useful, feasible, and safe modality for cardiac catheterization in the pediatric cardiac catheterization laboratory.
传统的儿科心导管插入术方法依赖股静脉通路。上肢静脉通路可使心导管插入术用于诊断性和介入性导管插入术时能安全进行。这项多中心研究的目的是证明在儿科心导管插入实验室中上肢静脉通路的可行性和安全性。
对所有通过上肢血管通路进行心导管插入术的患者进行回顾性病历审查。
对72例患者尝试通过上肢静脉进行82次心导管插入术。67例患者的75次导管插入术(91%)成功获得通路。导管插入术时的中位年龄为18.79岁(四分位间距[IQR],13.02 - 32.75岁;n = 75),中位体重为59.4 kg(IQR,43.3 - 76.5 kg;n = 75)。最年轻的患者为4.1个月大,体重4.3 kg。46例手术(61%)采用局部麻醉或轻度镇静。诊断性右心导管插入术是最常见的手术(n = 65;87%),8例(11%)通过上肢进行介入操作。中位透视时间为10.02分钟(IQR,2.87 - 36.26分钟;n = 75),剂量面积乘积/体重为3.765 μGy•m²/kg(IQR,0.74 - 34.12 μGy•m²/kg;n = 64)。中位鞘管留置时间为48分钟(IQR,19.5 - 147分钟;n = 57),中位总手术时间为116分钟(IQR,80.5 - 299分钟;n = 65)。门诊手术的中位住院时间为5.37小时(IQR,4.25 - 6.92小时;n = 27)。无手术并发症。
上肢静脉通路是儿科心导管插入实验室中心导管插入术的一种有用、可行且安全的方式。